Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prevalence of Pulmonary Embolism in Patients With Syncope

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Shift From Adalimumab Originator to Biosimilars in Denmark

    Research output: Contribution to journalLetterResearchpeer-review

  2. Association of Healthy Lifestyle With Years Lived Without Major Chronic Diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Reform of the National Screening Mammography Program in France

    Research output: Contribution to journalComment/debateResearch

  1. Return to work after COVID-19 infection - A Danish nationwide registry study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Protocol for detecting unrecognized sleep apnea in patients with atrial fibrillation by a home-monitoring device: the DAN-APNO study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Treatment of Older Patients with Atrial Fibrillation by Morbidity Burden

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Importance: Sparse data and conflicting evidence exist on the prevalence of pulmonary embolism (PE) in patients with syncope.

Objective: To estimate the prevalence of PE among patients presenting to the emergency department (ED) for evaluation of syncope.

Design, Setting, and Participants: This retrospective, observational study analyzed longitudinal administrative data from 5 databases in 4 different countries (Canada, Denmark, Italy, and the United States). Data from all adult patients (aged ≥18 years) who presented to the ED were screened to identify those with syncope codes at discharge. Data were collected from January 1, 2000, through September 30, 2016.

Main Outcomes and Measures: The prevalence of PE at ED and hospital discharge, identified using codes from the International Classification of Diseases, was considered the primary outcome. Two sensitivity analyses considering prevalence of PE at 90 days of follow-up and prevalence of venous thromboembolism were performed.

Results: A total of 1 671 944 unselected adults who presented to the ED for syncope were included. The prevalence of PE, according to administrative data, ranged from 0.06% (95% CI, 0.05%-0.06%) to 0.55% (95% CI, 0.50%-0.61%) for all patients and from 0.15% (95% CI, 0.14%-0.16%) to 2.10% (95% CI, 1.84%-2.39%) for hospitalized patients. The prevalence of PE at 90 days of follow-up ranged from 0.14% (95% CI, 0.13%-0.14%) to 0.83% (95% CI, 0.80%-0.86%) for all patients and from 0.35% (95% CI, 0.34%-0.37%) to 2.63% (95% CI, 2.34%-2.95%) for hospitalized patients. Finally, the prevalence of venous thromboembolism at 90 days ranged from 0.30% (95% CI, 0.29%-0.31%) to 1.37% (95% CI, 1.33%-1.41%) for all patients and from 0.75% (95% CI, 0.73%-0.78%) to 3.86% (95% CI, 3.51%-4.24%) for hospitalized patients.

Conclusions and Relevance: Pulmonary embolism was rarely identified in patients with syncope. Although PE should be considered in every patient, not all patients should undergo evaluation for PE.

Original languageEnglish
JournalJAMA Internal Medicine
Volume178
Issue number3
Pages (from-to)356-362
Number of pages7
ISSN2168-6106
DOIs
Publication statusPublished - 1 Mar 2018

ID: 54607614